Ovarian Vein Thrombosis

Lenz, Charles J.; Wysokiński, Waldemar E.; Henkin, Stanislav; Cohoon, Kevin P.; Casanegra, Ana I.; Simmons, Benjamin; Saadiq, Rayya A.; Daniels, Paul; Wysokinska, Ewa M.; Bjarnason, Haraldur; McBane, Robert D.

doi:10.1097/aog.0000000000002319

Cited by 50 publications

(33 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Plastini et al found that in patients with OVT treated with anticoagulation and in those without treatment there was no correlation found in terms of overall outcome [11]. However, a recent case-control study by Lenz CJ et al looked at the risk of venous thromboembolism recurrence, major bleeding and mortality among those who got diagnosed with ovarian vein thrombosis and found that although patients with OVT are treated less often (54%) as compared to patients who got diagnosed with lower extremity DVT (98%), the recurrence rate of venous thromboembolism was similar between these two groups (2.3% in OVT vs 1.8 in DVT ) arguing that anticoagulation with a direct oral anticoagulation or vitamin K antagonist should be considered especially in patients who have a personal history of venous thromboembolism [1]. We choose to administer the patient with anticoagulant and she did respond well.…”

Section: Discussionmentioning

confidence: 99%

“…Ovarian Vein Thrombosis (OVT) is a relatively rare and uncommon thrombotic condition commonly attributed to the postpartum period. It has been shown to complicate 1 in 600 to 1 in 1200 pregnancies [1]. It is more common after cesarean section than spontaneous vaginal delivery [2].…”

Section: Introductionmentioning

confidence: 99%

“…It is more common after cesarean section than spontaneous vaginal delivery [2]. It is reported in gynecologic abdominal and pelvic surgery, malignancy, pelvic inflammatory disease and inflammatory bowel diseases and other conditions that can cause thrombus formation in the ovarian veins [3][4][5]. With the increased trend of laparoscopic gynecologic surgeries, OVT is also reported in patients who had undergone minimally invasive surgeries [6][7].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Left Ovarian Vein Thrombosis Presenting as Acute Postpartum Pyelonephritis

Azhar¹,

Nguyen²,

Waheed³

2020

Cureus

View full text Add to dashboard Cite

Ovarian Vein Thrombosis (OVT) is an extremely rare and uncommon thrombotic condition commonly attributed to the postpartum period. We report a case of a 30 yr old P2002 who presented with one day history of fever, chills, vomiting, abdominal and left flank pain. Patient had a preterm vaginal birth at 34 weeks gestation, four days prior to her presentation. Patient was febrile on presentation with left CVA tenderness and diffuse abdominal tenderness. Pelvic Ultrasound showed enlarged uterus 14.7cm x 10.9cm x 8.5cm consistent with a postpartum uterus, with heterogeneous endometrium 2.3 cm, no retained products and normal adnexa. CT scan with contrast showed fluid along the anterior aspect of the left anterior kidney, left psoas muscle and extending down to the left side of the uterus and extending to the region of the left renal vein which confirmed left ovarian thrombosis. A CT Chest with contrast and bilateral lower extremity Doppler ruled out pulmonary embolism and deep vein thrombosis, respectively.The patient was admitted, treated with antibiotics and therapeutic dose of low molecular weight heparin (Enoxaparin) and responded well. Patient was discharged home on oral apixaban. The clinical presentation of OVT is non-specific and can be similar to that of acute pyelonephritis. Physicians should have a high index of suspicion in postpartum patients presenting with flank pain and imaging techniques such as MRI, CT scan and ultrasound should be used to help in making the diagnosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Left Ovarian Vein Thrombosis Presenting as Acute Postpartum Pyelonephritis

Azhar¹,

Nguyen²,

Waheed³

2020

Cureus

View full text Add to dashboard Cite

show abstract

“…Current clinical practice is that patients with acute GVT are treated with anticoagulation for 3 to 6 months. 6,7,28,29 Information about the use of DOACs for GVT is limited to a few case reports. 27,30 It continues to be the practice of Mayo Thrombophilia Clinic to provide anticoagulant therapy that includes also DO-ACs to patients with GVT in the absence of a direct contraindication, such as major bleeding.…”

Section: Introductionmentioning

confidence: 99%

“…27,30 It continues to be the practice of Mayo Thrombophilia Clinic to provide anticoagulant therapy that includes also DO-ACs to patients with GVT in the absence of a direct contraindication, such as major bleeding. 6,27 Renal vein thrombosis Renal vein thrombosis (RVT) is highly associated with underlying malignancy, particularly renal cell carcinoma. 5 Invasion of this cancer to the renal vein with extension to the inferior vena cava is often called tumor thrombus and thought not to require anticoagulation.…”

Section: Introductionmentioning

confidence: 99%

Thrombosis of atypical location: how to treat patients in the era of direct oral anticoagulants?

Mimier

Jańczak

McBane³

et al. 2018

Polish Archives of Internal Medicine

Self Cite

View full text Add to dashboard Cite

Direct oral anticoagulants for unusual‐site venous thromboembolism

Riva

Ageno

2021

Research and Practice in Thrombosis and Haemostasis

View full text Add to dashboard Cite

Direct oral anticoagulants (DOACs) are currently the preferred oral anticoagulant treatment for most of the patients with deep vein thrombosis of the lower extremities and/or pulmonary embolism. DOACs have several advantages over vitamin K antagonists, such as availability of fixed dosages, fewer drug interactions, faster onset of action, shorter half‐life, and lower risk of major and intracranial bleeding. Although the evidence on the use of DOACs in patients with unusual‐site venous thromboembolism (VTE) is limited to a few, small randomized controlled trials, these drugs are increasingly used in clinical practice, and several observational cohort studies have been published recently. This narrative review will describe the latest evidence for the use of the DOACs in patients with thrombosis in atypical locations (splanchnic, cerebral, upper extremity, ovarian, and renal vein thrombosis) and will provide some practical advice for their use in patients with unusual‐site VTE.

show abstract

Ovarian Vein Thrombosis

Cited by 50 publications

References 22 publications

Left Ovarian Vein Thrombosis Presenting as Acute Postpartum Pyelonephritis

Left Ovarian Vein Thrombosis Presenting as Acute Postpartum Pyelonephritis

Thrombosis of atypical location: how to treat patients in the era of direct oral anticoagulants?

Direct oral anticoagulants for unusual‐site venous thromboembolism

Contact Info

Product

Resources

About